Experience

Universitätsklinikum Würzburg

• Germany
• Hospitals and Health Care
• 700 & Above Employee

• Scientific and Strategic Project Manager - Cellular Immunotherapy Program

  • Nov 2020 - Present

  Carmen Sanges holds a PhD in Medical Biotechnology and is currently the EU Scientific Project Lead of the Cellular Immunotherapy Program at the University Clinic Würzburg. Her recent experience includes coordinating and advising numerous initiatives funded by the European Commission under the Horizon 2020 framework, including T2EVOLVE. She is particularly involved in developing synergistic approaches across multiple EU consortia in the field of cell and gene therapy, with the aim of leveraging… Show more Carmen Sanges holds a PhD in Medical Biotechnology and is currently the EU Scientific Project Lead of the Cellular Immunotherapy Program at the University Clinic Würzburg. Her recent experience includes coordinating and advising numerous initiatives funded by the European Commission under the Horizon 2020 framework, including T2EVOLVE. She is particularly involved in developing synergistic approaches across multiple EU consortia in the field of cell and gene therapy, with the aim of leveraging the potential, and accelerating the achievements of the different projects. As part of the lead coordinators' team, I oversee the European #T2EVOLVE consortium, supporting WP leaders and co-leaders in strategic decisions and bridging synergies, and facilitate communication and clarity between consortium partners and within the different WPs. Actively involved in the stakeholder community building and accelerant projects establishment between stakeholder community members and T2EVOLVE partners. Organizing, leading, and moderating focused discussions and roundtables across the community. Part of the comms&dissemination core group taking care of the T2EVOLVE vision and mission spread. Come and join us: www.t2evolve.com In the context of the #AIDATH consortium, I am responsible for the clinical readiness, regulatory approach strategy and stakeholder engagement program that will allow the clinical application of this innovative AI-driven ATMP manufacturing platform https://www.sciencrew.com/c/6499?title=AIDPATH Proud member of the Regulatory Board in ImSAVAR EU project https://imsavar.eu/ Engaged member of the EUCCAT working group at EUHA https://www.euhalliance.eu/ Partner in the #JOIN4ATMP European initiative as a connector member facilitating synergies between T2EVOLVE and the #JOIN4ATMP program. Proud member of the Advisory Board of the #ASCERTAIN project Show less Carmen Sanges holds a PhD in Medical Biotechnology and is currently the EU Scientific Project Lead of the Cellular Immunotherapy Program at the University Clinic Würzburg. Her recent experience includes coordinating and advising numerous initiatives funded by the European Commission under the Horizon 2020 framework, including T2EVOLVE. She is particularly involved in developing synergistic approaches across multiple EU consortia in the field of cell and gene therapy, with the aim of leveraging… Show more Carmen Sanges holds a PhD in Medical Biotechnology and is currently the EU Scientific Project Lead of the Cellular Immunotherapy Program at the University Clinic Würzburg. Her recent experience includes coordinating and advising numerous initiatives funded by the European Commission under the Horizon 2020 framework, including T2EVOLVE. She is particularly involved in developing synergistic approaches across multiple EU consortia in the field of cell and gene therapy, with the aim of leveraging the potential, and accelerating the achievements of the different projects. As part of the lead coordinators' team, I oversee the European #T2EVOLVE consortium, supporting WP leaders and co-leaders in strategic decisions and bridging synergies, and facilitate communication and clarity between consortium partners and within the different WPs. Actively involved in the stakeholder community building and accelerant projects establishment between stakeholder community members and T2EVOLVE partners. Organizing, leading, and moderating focused discussions and roundtables across the community. Part of the comms&dissemination core group taking care of the T2EVOLVE vision and mission spread. Come and join us: www.t2evolve.com In the context of the #AIDATH consortium, I am responsible for the clinical readiness, regulatory approach strategy and stakeholder engagement program that will allow the clinical application of this innovative AI-driven ATMP manufacturing platform https://www.sciencrew.com/c/6499?title=AIDPATH Proud member of the Regulatory Board in ImSAVAR EU project https://imsavar.eu/ Engaged member of the EUCCAT working group at EUHA https://www.euhalliance.eu/ Partner in the #JOIN4ATMP European initiative as a connector member facilitating synergies between T2EVOLVE and the #JOIN4ATMP program. Proud member of the Advisory Board of the #ASCERTAIN project Show less



ERT

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Project Manager, Clinical Operations

  • Jun 2017 - Oct 2019

  Responsible for directing and managing services for client projects to assure high quality, on-time, and on-budget services while promoting excellent customer service. Lead the Planning and Setup, Monitoring, and Closeout phases of study management. Identify potential study risks and mitigations, and escalate as appropriate. Preparation and delivery of training material for new onboard colleagues. Founder and leader of the "ERT Science Project" aimed to give more scientific insights… Show more Responsible for directing and managing services for client projects to assure high quality, on-time, and on-budget services while promoting excellent customer service. Lead the Planning and Setup, Monitoring, and Closeout phases of study management. Identify potential study risks and mitigations, and escalate as appropriate. Preparation and delivery of training material for new onboard colleagues. Founder and leader of the "ERT Science Project" aimed to give more scientific insights and material on the different clinical trials partnered by ERT.

• Relationship Management, Coordinator

  • Sep 2016 - May 2017

  1. Deliver superior customer service by providing best business practices and support in using ERT’s products for the duration of client’s clinical trials 2. Work and collaborate with project team/s of diverse talents (Project Manager, Software Engineer, Database Engineer, Archive team, etc) in development and delivery of ERT products to help clinical research industry obtain high-quality data. 3. When requested, pro-actively manage lifecycle of issues from being reported by customer to… Show more 1. Deliver superior customer service by providing best business practices and support in using ERT’s products for the duration of client’s clinical trials 2. Work and collaborate with project team/s of diverse talents (Project Manager, Software Engineer, Database Engineer, Archive team, etc) in development and delivery of ERT products to help clinical research industry obtain high-quality data. 3. When requested, pro-actively manage lifecycle of issues from being reported by customer to its resolution by the support and development teams. 4. Record, analyse and track Key Performance Indicators (KPIs), metrics and sponsor/compound level issues. 5. Analyze business processes and identify potential process improvements. 6. Provide quantitative and qualitative data analysis and reporting of patterns, insights and trends to decision-makers. Perform gap analysis and feasibility analysis. 7. Support Relationship Managers in the development of documentation, trend analysis and industry business intelligence to support Governance and Operational meetings. 8. When required, meet with clients to provide monitoring updates, track ongoing issues and communicate project status.

• Account and Project Manager Assistant

  • Sep 2012 - Aug 2016


Cactus Communications
• India
• Software Development
• 700 & Above Employee
• Freelance scientific editor

  • Aug 2012 - Mar 2014


Independent scientific editing

• Scientific writer

  • Jan 2010 - Sep 2012

  Elaboration, drafting and editing of scientific works, such as papers, reviews, book's chapters and more. Please contact me for a detailed list of pubblications. Elaboration, drafting and editing of scientific works, such as papers, reviews, book's chapters and more. Please contact me for a detailed list of pubblications.



Biochemistry and Medical Biotechnology Department - Università degli studi di Napoli "FedericoII"

• PhD in Biochemistry and Cellular and Molecular Biology

  • Oct 2006 - Jan 2010

  During these years, my research has been focused on the mechanisms regulating the limited activity of IFN alpha in human hepidermoid lung cancer. This point has been driving my studies, leading to the discovery of an intriguing relationship between the eukaryotic elongation factor 1A and RAF kinases during a survival response against apoptosis induced by IFN alpha treatment in H1355 cells. In particular, in the last period, I’ve been working to elucidate the interaction with and the… Show more During these years, my research has been focused on the mechanisms regulating the limited activity of IFN alpha in human hepidermoid lung cancer. This point has been driving my studies, leading to the discovery of an intriguing relationship between the eukaryotic elongation factor 1A and RAF kinases during a survival response against apoptosis induced by IFN alpha treatment in H1355 cells. In particular, in the last period, I’ve been working to elucidate the interaction with and the modification induced by RAF kinases on both the elongation factor’s isoforms. Moreover I have been working on the construction of DNA optical biosensors. The initial approach of the work regarded the functionalization of porous silicon and its use as a support for the realization of the DNA biochip. The technical approaches employed were Infrared Spectroscopy with Fourier transformed and fluorescence. Other investigation concerned the fabrication of a new optical biosensor based on Peptide Nucleic Acid (PNA) for the selective identification of single mutation. Show less During these years, my research has been focused on the mechanisms regulating the limited activity of IFN alpha in human hepidermoid lung cancer. This point has been driving my studies, leading to the discovery of an intriguing relationship between the eukaryotic elongation factor 1A and RAF kinases during a survival response against apoptosis induced by IFN alpha treatment in H1355 cells. In particular, in the last period, I’ve been working to elucidate the interaction with and the… Show more During these years, my research has been focused on the mechanisms regulating the limited activity of IFN alpha in human hepidermoid lung cancer. This point has been driving my studies, leading to the discovery of an intriguing relationship between the eukaryotic elongation factor 1A and RAF kinases during a survival response against apoptosis induced by IFN alpha treatment in H1355 cells. In particular, in the last period, I’ve been working to elucidate the interaction with and the modification induced by RAF kinases on both the elongation factor’s isoforms. Moreover I have been working on the construction of DNA optical biosensors. The initial approach of the work regarded the functionalization of porous silicon and its use as a support for the realization of the DNA biochip. The technical approaches employed were Infrared Spectroscopy with Fourier transformed and fluorescence. Other investigation concerned the fabrication of a new optical biosensor based on Peptide Nucleic Acid (PNA) for the selective identification of single mutation. Show less



Institute of Medical Radiation and Cell Research (MSZ)

• Recipient of “Deutsch-Italienisches Hochschulzentrum” fellowship (Vigoni Project 2008-2009)

  • Jan 2009 - Oct 2009

  In order to complete the PhD thesis I've been joining the biochemistry group of Prof. Ulf R. Rapp as part of the “Vigoni Project”, a scientific cooperation program between Italy and Germany. In order to complete the PhD thesis I've been joining the biochemistry group of Prof. Ulf R. Rapp as part of the “Vigoni Project”, a scientific cooperation program between Italy and Germany.



Farma - derma s.r.l.

• Italy
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• medical representative

  • 2004 - 2006

  Consulting and information of clinical studies and pharmacological characteristics, public relations and product promotion. http://www.farmaderma.it/index-en.html Consulting and information of clinical studies and pharmacological characteristics, public relations and product promotion. http://www.farmaderma.it/index-en.html



Cieffe Derma s.r.l.

• medical representative

  • 2003 - 2003

  Consulting and information of clinical studies and pharmacological characteristics, public relations and product promotion. Consulting and information of clinical studies and pharmacological characteristics, public relations and product promotion.